skip to main | skip to sidebar

Betty health

As new parents, let us give you some advice. Click below and save yourself some cash with $500 worth of free* Huggiesr or Pampersr Diapers and Wipes. Then again, you probably already know it's good to save where you can.

Thursday, April 9, 2009

Bristol, Biogen CEOs: We’re Not Rushing to Be Acquired

But they aren't ruling it out, either.
Posted by Betty at 2:48 PM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ▼  2009 (958)
    • ►  August (18)
    • ►  July (123)
    • ►  June (129)
    • ►  May (117)
    • ▼  April (116)
      • Free From Uncle Sam: VA Software for Hospital EHS ...
      • Companies Look to Shift More Health Costs to Workers
      • Live Blog: CDC Swine-Flu Update
      • Live Blog: CDC Swine Flu Update
      • Medicare May Pay More For Primary-Care Docs, Rural...
      • Tracking the Swine Flu Outbreak: Thursday
      • Provenge Data Give Dendreon a Takeover Glow
      • Considering the Range of Pandemics
      • Live Blog: Swine Flu Update from WHO Director-General
      • Live Blog: Swine Flu Update from WHO Director-Gene...
      • Live Blog: Swine Flu Update from WHO Director-General
      • Swine Flu? H1N1? What’s In a Name?
      • After Yesterday’s Storm, Sun Shines Again on Dendr...
      • Search for Swine Flu’s Patient Zero Leads to Mexic...
      • After Swearing In, Sebelius Talks Swine Flu in Sit...
      • Plunging Stock Price Rains on Dendreon’s Provenge ...
      • Swine Flu: Live Blogging CDC’s Tuesday Call
      • Headless Health Agencies Face Swine Flu
      • IOM Talks Softly, Carries Big Stick on Doctor Conf...
      • Live Blog: WHO Tuesday Call
      • Pfizer Roundup: Lipitor Sales Fall, Biotech Chief ...
      • A Century of Flu Pandemics
      • Amid Swine Flu Outbreak, N95 Masks Placed on Back ...
      • Swine Flu at Alert Phase 4: ‘Mitigation,’ Not ‘Con...
      • If Primary-Care Docs Are Paid More, Will Specialis...
      • Understanding the WHO’s Global Pandemic-Alert Levels
      • Swine Flu: Live Blogging CDC’s Monday Conference Call
      • Glaxo, Roche Start to Map Swine-Flu Game Plans
      • What’s Confusing About Swine Flu
      • Health Blog Q&A: Swine Flu in the U.S. and Mexico
      • Abbott Shareholders Don’t Want Say On Exec Pay
      • Number of Malpractice Suits Falls 41% in Pennsylvania
      • As Insurance Coverage Increases, ERs Get Busier
      • War Against Cancer: A Long, Hard Slog
      • Swine Flu: Look Hard Enough, and You’ll See Strang...
      • Embryonic Stem Cells Without Embryos, Cont’d
      • Pfizer Holders Want Say on Exec Pay; J&J Holders, ...
      • Patients: There’s Waste in Medicine, but My Doctor...
      • Specialty Matters When Implanting Defibrillators
      • Boston Medical School in Awkward Spot After Craigs...
      • Does Avastin Trial Mean Roche Paid Too Much for Ge...
      • Sebelius Wins Committee Vote Despite Abortion Cont...
      • Where Medical Boards Do and Don’t Crack Down on Do...
      • Merck Suffers Blow Developing New Migraine Drug
      • Debate Over Public Plan Pulls Health Reform Past ‘...
      • 10 Reasons Doctors Get Burned Out
      • As Nest Eggs Shrink, Some Doctors Try to Return Fr...
      • WellPoint Makes Three Million Calls In Health-Refo...
      • Amid Talk of Reform, Health-Clinic Lines Grow
      • Friendlier Skies in Canada for Overweight Passengers
      • Universal Care Could Be Thwarted by Disappearing Docs
      • Silicone Can Carry High Cost in Bid to Look Good
      • Trying to Fill In the Blanks in FDA’s Rules on Web...
      • Feds: Watch Out for Exploding Fitness Balls
      • Roche and Genentech Break Down Some R&D Walls
      • Eli Lilly Tops List of Drug-Company Pay to Vermont...
      • Pharma Sales Reps Often Find the Doc Won’t See The...
      • Fresh Off Wyeth Deal, Pfizer Inks HIV Pact with Glaxo
      • Nancy-Ann DeParle’s Definition of ‘Public’ Health ...
      • Study Author in JAMA Disclosure Flap Has His Say
      • Abbott CEO: ‘We’re Not Necessarily Looking for any...
      • Merck Exec on R&D: ‘Nothing Is Safe From Cuts’
      • Roche Exec Takes Over As Genentech CEO
      • After Falling for Fake Study, Review Board Steps A...
      • Dendreon’s Shares Come Back to Life on Prostate Ca...
      • Diabetics Visiting the ER Have Greater Chance of D...
      • Generics, Recession Take Bites Out of J&J’s Profit
      • Finding Referrals for Mental-Health Patients Often...
      • Drug Makers Talk Up Comparative Effectiveness, Sor...
      • Heart Health: Mediterranean Diet Good, Trans Fats Bad
      • How Much Will Higher Taxes, Price Hikes Damp Cigar...
      • What the Recession Means for Hospitals, Nurses
      • Fraud Hits Home Health-Care Program
      • What the Recession Means for Hospitals, Nurses
      • Fraud Hits Home Health-Care Program
      • What’s the Best Way to Manage Prescription-Drug Be...
      • Icahn Tries to Shake Up Boards at Amylin and Biogen
      • Researcher Faked Data in Sleep Apnea Study
      • Harvard-Affiliated Hospitals to Limit Docs’ Indust...
      • Bristol, Biogen CEOs: We’re Not Rushing to Be Acqu...
      • Reality Check on Foodborne Illness Rate
      • Girl With Genetic Disease Sues Sperm Bank
      • Hospital Settles Over ‘Dumping’ Homeless Patients
      • Big Pharma’s Global Generics Push Continues With S...
      • Wait, What Is Brown Fat?
      • Time for Soda Tax? Backers Want to Cut Obesity, Ai...
      • FDA Takes New Look at Female Condoms, External Def...
      • Johns Hopkins Bans Free Drug Samples, Gifts from I...
      • Illegal Immigrant Used Stolen Identity to Get Hosp...
      • How Quality-of-Care Rules Can Lead Doctors Astray
      • If China Builds Hospitals, Patients Will Come
      • More Prescriptions for Generics, Fewer for Branded...
      • Shares of Medicare Advantage Companies Rise On New...
      • Reorganizing Drug R&D: $62 Billion Merger Not Requ...
      • Reorganizing Big Pharma R&D: $62 Billion Merger No...
      • Citing Economy, AMA Announces 100 Layoffs
      • Torti’s Farewell Memo to FDA Staff: ‘Take the FDA ...
      • Does the World Need a Prescription Drug for Jet Lag?
      • Abortion Foes Call Republican Response to Sebelius...
      • Pfizer Closes In on Settlement Over Drug Trial of ...
      • Abilify Deal Gives Bristol-Myers Some Breathing Room
      • Oops! Seroquel Documents Bounce On and Off FDA Web...
      • What FDA Diabetes Panel’s Novo Nordisk Vote Means ...
      • Nurse Charged With Killing Dialysis Patients With ...
      • Sebelius Nomination May Shift to Slow Track
      • Tobacco’s Regulator May Soon Be Same As Pharma’s
      • GE, Intel, Google, IBM, Microsoft & Home-Health Mo...
      • Testing of Alzheimer’s Treatment Is Curbed by Wyet...
      • Conservative Critic of Obama on Health Reform Has ...
      • Hospital Doors Revolve for Many Medicare Patients
      • Is Earlier Better for AIDS Treatment?
      • Potential Buyers Kick the Tires of Solvay’s Drug B...
      • Television Viewers Offer Kidneys to Natalie Cole
      • FDA Advisers Support Avastin for Brain Cancer
      • Sebelius Runs Into Tax Problems, But Daschle’s Wer...
      • As Angioplasty Declines, Are Patients Helped or Ha...
    • ►  March (174)
    • ►  February (144)
    • ►  January (137)
  • ►  2008 (1352)
    • ►  December (159)
    • ►  November (172)
    • ►  October (139)
    • ►  September (133)
    • ►  August (115)
    • ►  July (141)
    • ►  June (132)
    • ►  May (156)
    • ►  April (151)
    • ►  March (54)